• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: US SURGICAL PUERTO RICO ENDO GIA ULTRA; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

US SURGICAL PUERTO RICO ENDO GIA ULTRA; STAPLE, IMPLANTABLE Back to Search Results
Model Number EGIAUSHORT
Device Problems Entrapment of Device (1212); Failure to Fire (2610); Component or Accessory Incompatibility (2897)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/01/2023
Event Type  malfunction  
Event Description
According to the reporter, during a laparoscopic procedure, during small intestinal resection, device could not be loaded properly, and firing could not be performed, but surgeon could press the green button.Jaws were fixated to tissue and removed.Attempts were made to connect the first handle returned this time, first reload to second handle, and second reload etc., but when both first handle and first reload were used, the device could not be properly squeezed.Firing could only be performed with the combination of second reload and second handle.There was no patient injury.
 
Manufacturer Narrative
H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted the instrument was loaded and clamped but would not cycle due to sheared firing rack teeth damage.It was reported that the device did not fire and the jaws of the device remain closed on tissue.The reported issues were confirmed.The product analysis noted evidence that the device was not used as intended.It was also reported that the device was difficult to load.The reported issue could not be confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.The instructions included with this device provide the following guidance: failure to completely fire the reload will result in an incomplete cut or incomplete staple formation, which may result in poor hemostasis or leakage.Always inspect the tissue thickness and select an appropriate staple size prior to application of the endo gia¿ ultra universal short, endo gia¿ ultra universal or endo gia¿ ultra universal xl stapler.Overly thick or thin tissue may result in unacceptable staple formation.When positioning the stapler on the application site, ensure that no obstructions, such as clips, are incorporated into the instrument jaws.Firing over an obstruction may result in incomplete cutting action or improperly formed staples.D10 concomitant product: egia60avm, egia60avm egia 60 artic vasc med sulu (lot#p2j0102); medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: b5, g3 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, during a laparoscopic procedure, during small intestinal resection, device could not be loaded properly, and firing could not be performed, but surgeon could press the green button.Jaws were fixated to tissue and removed in the usual way.Attempts were made to connect the first handle returned this time, first reload to second handle, and second reload etc., but when both first handle and first reload were used, the device could not be properly squeezed.Firing could only be performed with the combination of second reload and second handle.There was no patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDO GIA ULTRA
Type of Device
STAPLE, IMPLANTABLE
Manufacturer (Section D)
US SURGICAL PUERTO RICO
201 sabanetas industrial park
ponce PR 00716 4401
Manufacturer (Section G)
US SURGICAL PUERTO RICO
201 sabanetas industrial park
ponce PR 00716 4401
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key17791158
MDR Text Key323960355
Report Number2647580-2023-04124
Device Sequence Number1
Product Code GDW
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K111825
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberEGIAUSHORT
Device Catalogue NumberEGIAUSHORT
Device Lot NumberP3D0498
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/06/2023
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/04/2023
Initial Date FDA Received09/21/2023
Supplement Dates Manufacturer Received09/13/2023
Supplement Dates FDA Received10/04/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PLEASE SEE NOTE ON H10
-
-